![Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire](https://mms.businesswire.com/media/20210505005037/en/875837/4/480.jpg)
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire
![Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock](https://iknowfirst.com/wp-content/uploads/2018/05/Screen-Shot-2018-05-22-at-12.23.31-PM.png)
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
![Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat](https://www.marketbeat.com/logos/teva-pharmaceutical-industries-limited-logo.png?v=20221109123024)
Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat
![US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond](https://images.fintel.io/us-us88167aae10-so.png)
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond
![Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1642603837/teva1_1.jpg/teva1_1.jpg?VersionId=nO05_Vv2BJv9MBUgDNsNaIO1LnDj7m4Q)
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
![Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/FiercePharma-1505229128/17283526416_7e5c6e438c_k.jpg?VersionId=g5MXdu7hICaoWTUcJ9FyMWwOvrt6s9vQ)